ANTIBACTERIAL ACTIVITY OF CEFPODOXIME AGAINST BRANHAMELLA-CATARRHALIS

被引:2
作者
TAKENOUCHI, T [1 ]
NISHINO, T [1 ]
机构
[1] KYOTO PHARMACEUT UNIV,DEPT MICROBIOL,KYOTO 607,JAPAN
关键词
D O I
10.1111/j.1348-0421.1991.tb01628.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The antibacterial activity of cefpodoxime against Branhamella catarrhalis was studied. All of the 65 clinical isolates tested were inhibited at and below 1.56-mu-g/ml, both at 10(7) and at 10(5) CFUs. The following was further studied on B. catarrhalis N-5 which showed average susceptibility to each drug examined. Bactericidal activity was observed at and above the MIC. Scanning and transmission electron microscopy revealed morphological changes, such as cellular swelling, bleb formation, inhibition of septum formation, and lysis, of the cells exposed to cefpodoxime at concentrations around the MIC. Cefpodoxime was poorly hydrolyzed by the beta-lactamase and it showed affinity for two penicillin-binding proteins that had approximate molecular weights of 83 and 74 kilodaltons, with I50 values of 3.7 and 2.1-mu-g/ml. respectively.
引用
收藏
页码:1059 / 1071
页数:13
相关论文
共 33 条
[1]   ANTIMICROBIAL SUSCEPTIBILITY OF BRANHAMELLA-CATARRHALIS ISOLATES FROM BRONCHOPULMONARY INFECTIONS [J].
AHMAD, F ;
MCLEOD, DT ;
CROUGHAN, MJ ;
CALDER, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (03) :424-425
[2]   INVITRO SUSCEPTIBILITIES AND BETA-LACTAMASE PRODUCTION OF 53 CLINICAL ISOLATES OF BRANHAMELLA-CATARRHALIS [J].
ALVAREZ, S ;
JONES, M ;
HOLTSCLAWBERK, S ;
GUARDERAS, J ;
BERK, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (04) :646-647
[4]   BRANHAMELLA-CATARRHALIS - AN ORGANISM GAINING RESPECT AS A PATHOGEN [J].
CATLIN, BW .
CLINICAL MICROBIOLOGY REVIEWS, 1990, 3 (04) :293-320
[5]   ANTIBIOTIC SUSCEPTIBILITY OF BETA-LACTAMASE-PRODUCING STRAINS OF "BRANHAMELLA-(NEISSERIA)-CATARRHALIS [J].
DOERN, GV ;
SIEBERS, KG ;
HALLICK, LM ;
MORSE, SA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (01) :24-29
[6]   INVITRO ACTIVITIES OF 39 ANTIMICROBIAL AGENTS FOR BRANHAMELLA-CATARRHALIS AND COMPARISON OF RESULTS WITH DIFFERENT QUANTITATIVE SUSCEPTIBILITY TEST METHODS [J].
DOERN, GV ;
TUBERT, TA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (02) :259-261
[7]   BRANHAMELLA-CATARRHALIS - AN EMERGING HUMAN PATHOGEN [J].
DOERN, GV .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1986, 4 (03) :191-201
[8]   CHARACTERIZATION OF THE PLASMID-MEDIATED BETA-LACTAMASE IN BRANHAMELLA-CATARRHALIS, WITH SPECIAL REFERENCE TO SUBSTRATE AFFINITY [J].
ELIASSON, I ;
KAMME, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 (02) :139-149
[9]   BETA-LACTAMASES OF BRANHAMELLA-CATARRHALIS AND THEIR INHIBITION BY CLAVULANIC ACID [J].
FARMER, T ;
READING, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (03) :506-508
[10]   INVITRO ACTIVITY OF U-76,252 (CS-807), A NEW ORAL CEPHALOSPORIN [J].
FASS, RJ ;
HELSEL, VL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (07) :1082-1085